Gene · 29949
NIH grants978
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 978
Download this page as JSON| Grant | Title | IL19 papers | Newest fiscal year |
|---|---|---|---|
| P30GM124169 | ALS Efficiently Networking Advanced Beam Line Experiments (ALS-ENABLE) | 1 | 2025 |
| P42ES004705 | Toxic substances in the environment | 1 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 1 | 2025 |
| R01AI022553 | Molecular Analysis of Host Immune Response in Leprosy | 1 | 2025 |
| R01AI095983 | Genome-Wide Dissection of Mendelian Susceptibility to Mycobacterial Disease | 1 | 2025 |
| R01AI141479 | Mechanistic basis of bacteriophages for the decolonization of vancomycin resistant enterococci in the intestine | 1 | 2025 |
| R01AI150913 | Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect | 1 | 2025 |
| R01AI163029 | Inborn errors of immunity in patients with life-threatening COVID-19 | 1 | 2025 |
| R01AI163160 | Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling | 1 | 2025 |
| R01AR040312 | CD1-restricted T-cell Responses in Skin | 1 | 2025 |
| R01AR041836 | Function of Desmoglein 1/Pemphigus Foliaceus Antigen | 1 | 2025 |
| R01AR071384 | Characterization of interferon kappa as a novel target in cutaneous lupus | 1 | 2025 |
| R01AR073170 | Chromatin Dynamics During Epithelial Commitment | 1 | 2025 |
| R01CA177292 | Targeted Therapies for Lymphoid Malignancies | 1 | 2025 |
| R01CA228196 | Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma | 1 | 2025 |
| R01CA235375 | Delivery of cytokines for cancer immunotherapy using nanolayer-controlled trafficking of liposomal nanoparticles | 1 | 2025 |
| R01CA259599 | Interplay between tumor and microenvironment in bone metastasis | 1 | 2025 |
| R01CA262430 | Control of regulatory T cells by IL-17 in colorectal cancer | 1 | 2025 |
| R01CA262822 | Role of type 2 immune response in pancreatic cancer tumorigenesis | 1 | 2025 |
| R01DK076077 | Adaptive and maladaptive repair after kidney injury | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29949/grants?page=5